Jad Abi-Rafeh

Jad Abi-Rafeh

Auto-generated profile, based on publicly available information

Jad Abi-Rafeh

Division of Plastic, Reconstructive, and Aesthetic Surgery, McGill University Health Centre, Montreal, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
PDF file
JAJad Abi-Rafeh
Jad Abi-Rafeh
HXHong Hao Xu
Hong Hao Xu
RKRoy Kazan
Roy Kazan
RTRuth Tevlin
Ruth Tevlin
HFHeather Furnas
Heather Furnas
Background: The rapidly evolving field of artificial intelligence (AI) holds great potential for plastic surgeons. ChatGPT, a recently released AI large language model (LLM), promises applications across many disciplines, including healthcare. Objectives: The aim of this article was to provide a primer for plastic surgeons on AI, LLM, and ChatGPT, including an analysis of current demonstrated and proposed clinical applications. Methods: A systematic review was performed identifying medical and surgical literature on ChatGPT's proposed clinical applications. Variables assessed included applications investigated, command tasks provided, user input information, AI-emulated human skills, output validation, and reported limitations. Results: The analysis included 175 articles reporting on 13 plastic surgery applications and 116 additional clinical applications, categorized by field and purpose. Thirty-four applications within plastic surgery are thus proposed, with relevance to different target audiences, including attending plastic surgeons (n = 17, 50%), trainees/educators (n = 8, 24.0%), researchers/scholars (n = 7, 21%), and patients (n = 2, 6%). The 15 identified limitations of ChatGPT were categorized by training data, algorithm, and ethical considerations. Conclusions: Widespread use of ChatGPT in plastic surgery will depend on rigorous research of proposed applications to validate performance and address limitations. This systemic review aims to guide research, development, and regulation to safely adopt AI in plastic surgery.

1 May 2019 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
MAMeisam Asgari
Meisam Asgari
JAJad Abi-Rafeh
Jad Abi-Rafeh
GHGeoffrey N. Hendy
Geoffrey N. Hendy
DPDamiano Pasini
Damiano Pasini

6 February 2024 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
JAJad Abi-Rafeh
Jad Abi-Rafeh
NHNader Henry
Nader Henry
HXHong Hao Xu
Hong Hao Xu
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
AAAdel Arezki
Adel Arezki
FNFoad Nahai
Foad Nahai
Background: Large language models (LLMs) have revolutionized the way plastic surgeons and their patients can access and leverage artificial intelligence (AI). Objectives: The present study aims to compare the performance of 2 current publicly available and patient-accessible LLMs in the potential application of AI as postoperative medical support chatbots in an aesthetic surgeon's practice. Methods: Twenty-two simulated postoperative patient presentations following aesthetic breast plastic surgery were devised and expert-validated. Complications varied in their latency within the postoperative period, as well as urgency of required medical attention. In response to each patient-reported presentation, Open AI's ChatGPT and Google's Bard, in their unmodified and freely available versions, were objectively assessed for their comparative accuracy in generating an appropriate differential diagnosis, most-likely diagnosis, suggested medical disposition, treatments or interventions to begin from home, and/or red flag signs/symptoms indicating deterioration. Results: ChatGPT cumulatively and significantly outperformed Bard across all objective assessment metrics examined (66% vs 55%, respectively; P < .05). Accuracy in generating an appropriate differential diagnosis was 61% for ChatGPT vs 57% for Bard (P = .45). ChatGPT asked an average of 9.2 questions on history vs Bard’s 6.8 questions (P < .001), with accuracies of 91% vs 68% reporting the most-likely diagnosis, respectively (P < .01). Appropriate medical dispositions were suggested with accuracies of 50% by ChatGPT vs 41% by Bard (P = .40); appropriate home interventions/treatments with accuracies of 59% vs 55% (P = .94), and red flag signs/symptoms with accuracies of 79% vs 54% (P < .01), respectively. Detailed and comparative performance breakdowns according to complication latency and urgency are presented. Conclusions: ChatGPT represents the superior LLM for the potential application of AI technology in postoperative medical support chatbots. Imperfect performance and limitations discussed may guide the necessary refinement to facilitate adoption.

17 August 2023 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
JAJad Abi-Rafeh
Jad Abi-Rafeh
SHSteven Hanna
Steven Hanna
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
RKRoy Kazan
Roy Kazan
FNFoad Nahai
Foad Nahai

1 February 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IKIppei Kanazawa
Ippei Kanazawa
LCLucie Canaff
Lucie Canaff
JRJad Abi Rafeh
Jad Abi Rafeh
AAAarti Angrula
Aarti Angrula
JLJingjing Li
Jingjing Li
GHGeoffrey Hendy
Geoffrey Hendy
Menin, the product of the multiple endocrine neoplasia type 1 (Men1) tumor suppressor gene, mediates the cell proliferation and differentiation actions of transforming growth factor-beta (TGF-β) ligand family members. In vitro, menin modulates osteoblastogenesis and osteoblast differentiation promoted and sustained by bone morphogenetic protein-2 (BMP-2) and TGF-β, respectively. To examine the in vivo function of menin in bone, we conditionally inactivated Men1 in mature osteoblasts by crossing osteocalcin (OC)-Cre mice with floxed Men1 (Men1f/f) mice to generate mice lacking menin in differentiating osteoblasts (OC-Cre;Men1f/f mice). These mice displayed significant reduction in bone mineral density, trabecular bone volume and cortical bone thickness compared to control littermates. Osteoblast and osteoclast number, as well as mineral apposition rate (MAR) were significantly reduced, whereas osteocyte number was increased. Primary calvarial osteoblasts proliferated more quickly, but had deficient mineral apposition and alkaline phosphatase activity. While the mRNA expression of osteoblast marker and cyclin-dependent kinase inhibitor genes were all reduced, that of cyclin dependent kinase, osteocyte marker and pro-apoptotic genes were increased in isolated Men1 knockout osteoblasts compared to controls. In contrast to the knockout mice, transgenic mice overexpressing a human menin cDNA in osteoblasts driven by the 2.3-kb Col1a1 promoter, showed a gain of bone mass relative to control littermates. Osteoblast number and MAR were significantly increased in the Col1a1-Menin-Tg mice. Therefore, osteoblast menin plays a key role in bone development, remodeling and maintenance.

4 January 2024 in Aesthetic Surgery Journal Open Forum
Verified
Journal Article
Open access
PDF file
JAJad Abi-Rafeh
Jad Abi-Rafeh
BBBrian Bassiri-Tehrani
Brian Bassiri-Tehrani
RKRoy Kazan
Roy Kazan
HFHeather Furnas
Heather Furnas
DHDennis Hammond
Dennis Hammond
FNFoad Nahai
Foad Nahai
Background: At a time when Internet and social media use is omnipresent among patients in their self-directed research about their medical or surgical needs, artificial intelligence (AI) large language models (LLMs) are on track to represent hallmark resources in this context. Objectives: The authors aim to explore and assess the performance of a novel AI LLM in answering questions posed by simulated patients interested in aesthetic breast plastic surgery procedures. Methods: A publicly available AI LLM was queried using simulated interactions from the perspective of patients interested in breast augmentation, mastopexy, and breast reduction. Questions posed were standardized and categorized under aesthetic needs inquiries and awareness of appropriate procedures; patient candidacy and indications; procedure safety and risks; procedure information, steps, and techniques; patient assessment; preparation for surgery; postprocedure instructions and recovery; and procedure cost and surgeon recommendations. Using standardized Likert scales ranging from 1 to 10, 4 expert breast plastic surgeons evaluated responses provided by AI. A postparticipation survey assessed expert evaluators' experience with LLM technology, perceived utility, and limitations. Results: The overall performance across all question categories, assessment criteria, and procedures examined was 7.3/10 ± 0.5. Overall accuracy of information shared was scored at 7.1/10 ± 0.5; comprehensiveness at 7.0/10 ± 0.6; objectivity at 7.5/10 ± 0.4; safety at 7.5/10 ± 0.4; communication clarity at 7.3/10 ± 0.2; and acknowledgment of limitations at 7.7/10 ± 0.2. With regards to performance on procedures examined, the model's overall score was 7.0/10 ± 0.8 for breast augmentation; 7.6/10 ± 0.5 for mastopexy; and 7.4/10 ± 0.5 for breast reduction. The score on breast implant–specific knowledge was 6.7/10 ± 0.6. Conclusions: Albeit not without limitations, AI LLMs represent promising resources for patient guidance and patient education. The technology's machine learning capabilities may explain its improved performance efficiency. Level of Evidence: 4: